• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Rinaa S. Punglia, MD, MPH


  • Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS.Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ.Ann Surg Oncol. 2014 May 24.
  • Sher DJ, Punglia RS.Decision analysis and cost-effectiveness analysis for comparative effectiveness research--a primer.Semin Radiat Oncol. 2014 Jan;24(1):14-24.
  • Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ.Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Breast Cancer Res Treat. 2013 Oct;141(3):421-7.
  • Punglia RS, Schnitt SJ, Weeks JC.Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?.Journal of the National Cancer Institute. 2013 Oct 16;105(20):1527-33.
  • Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR.Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.Breast Cancer Res Treat. 2013 Jul;140(2):353-61.
  • Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS.Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.Journal of the National Cancer Institute. 2013 Jun 5;105(11):774-81.
  • Krishnan MS, Recht A, Bellon JR, Punglia RS.Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.Breast Cancer Res Treat. 2013 Feb;138(1):205-13.
  • Sher DJ, Parikh R, Mays-Jackson S, Punglia RS.Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer.Am J Clin Oncol. 2012 Dec 27.
  • Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS.Use of Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer in the United States.Int J Radiat Oncol Biol Phys. 2012 Oct 9.
  • Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR.Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ.Int J Radiat Oncol Biol Phys. 2012 Sep 10.
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ.Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.Cancer. 2012 Jun 6.
  • Sher DJ, Wee JO, Punglia RS.Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys. 2011 Feb 10.
  • Punglia RS, Hassett MJ.Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.J Clin Oncol. 2010 Sep 20;28(27):4108-10.
  • Punglia RS, Saito AM, Neville BA, Earle CC, Weeks JC.Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis.BMJ. 2010;340:c845.
  • Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK.Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.J Clin Oncol. 2009 Nov 10;27(32):5383-9.
  • Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC.Factors Associated with Guideline-Concordant Use of Radiotherapy After Mastectomy in the National Comprehensive Cancer Network.Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1434-40.
  • Sher DJ,Wittenberg E,Suh WW,Taghian AG,Punglia RS.Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):440-6.
  • Hoffman KE,Chen MH,Punglia RS,Beard CJ,D'Amico AV.Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.J Clin Oncol. 2008 Aug 20;26(24):3937-42.
  • Punglia RS, Burstein HJ, Winer EP, Weeks JC.Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.Journal of the National Cancer Institute. 2008 May 7;100(9):642-8.
  • Sher DJ, Wittenberg E, Taghian AG, Bellon JR, Punglia RS.Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis.Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):469-76.
  • Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV.Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.Cancer. 2007 Nov 1;110(9):1973-8.
  • Punglia RS, Morrow M, Winer EP, Harris JR.Local therapy and survival in breast cancer.N Engl J Med. 2007 Jun 7;356(23):2399-405. Review.
  • Landis DM, Luo W, Song J, Bellon JR, Punglia RS, Wong JS, Killoran JH, Gelman R, Harris JR.Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity.Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1299-308.
  • Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK.Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.J Clin Oncol. 2006 Sep 1;24(25):4116-22.
  • Punglia RS, Weeks JC, Neville BA, Earle CC.Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):56-63.
  • Punglia RS, Weeks JC, Neville BA, Earle CC.Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.J Clin Oncol. 2006 Jul 20;24(21):3474-82.
  • Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.Cancer. 2006 Jun 15;106(12):2576-82.
  • Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.Cancer. 2006 Apr 1;106(7):1507-13.
  • Punglia RS, Kuntz KM, Catalona WJ, D'Amico A.Operating characteristics of prostate-specific antigen and verification bias.JAMA. 2005 Dec 7;294(21):2698; author reply 2698-9.
  • Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.J Clin Oncol. 2005 Aug 1;23(22):5178-87.
  • Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.N Engl J Med. 2003 Jul 24;349(4):335-42.
  • Punglia RS, Kuntz KM, Lee JH, Recht A.Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.J Clin Oncol. 2003 Jun 15;21(12):2260-7.